| 3.02 0.005 (0.17%) | 07-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 3.77 | 1-year : | 4.41 |
| Resists | First : | 3.23 | Second : | 3.77 |
| Pivot price | 3.03 |
|||
| Supports | First : | 2.87 | Second : | 2.66 |
| MAs | MA(5) : | 3.05 |
MA(20) : | 2.99 |
| MA(100) : | 3.6 |
MA(250) : | 3.81 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 54.3 |
D(3) : | 63.5 |
| RSI | RSI(14): 49.7 |
|||
| 52-week | High : | 5.92 | Low : | 2.66 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SRTS ] has closed above bottom band by 40.3%. Bollinger Bands are 78.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.04 - 3.06 | 3.06 - 3.07 |
| Low: | 2.93 - 2.95 | 2.95 - 2.97 |
| Close: | 2.99 - 3.02 | 3.02 - 3.04 |
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
Wed, 15 Jul 2026
Sensus Healthcare (SRTS) Q4 2025 earnings summary - Quartr
Sun, 28 Jun 2026
Sensus Healthcare, Inc. (SRTS) Investigation: Bronstein, Gewirtz - The National Law Review
Fri, 26 Jun 2026
Enterprise value to revenue forward of Sensus Healthcare, Inc. – NASDAQ:SRTS - TradingView
Wed, 20 May 2026
How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes - Yahoo Finance
Fri, 08 May 2026
Sensus Healthcare Q1 Earnings Call Highlights - Yahoo Finance
Thu, 07 May 2026
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 16 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 17.6 (%) |
| Held by Institutions | 28.9 (%) |
| Shares Short | 201 (K) |
| Shares Short P.Month | 200 (K) |
| EPS | -0.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.76 |
| Profit Margin | -34.5 % |
| Operating Margin | -128.4 % |
| Return on Assets (ttm) | -13.5 % |
| Return on Equity (ttm) | -15.8 % |
| Qtrly Rev. Growth | -59.3 % |
| Gross Profit (p.s.) | 0.51 |
| Sales Per Share | 1.36 |
| EBITDA (p.s.) | -0.71 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | 3 (M) |
| PE Ratio | -6.17 |
| PEG Ratio | 0 |
| Price to Book value | 1.09 |
| Price to Sales | 2.2 |
| Price to Cash Flow | -90.72 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|